论文部分内容阅读
腹腔镜根治膀胱全切(laparoscopic radical cystectomy,LRC)或机器人辅助腹腔镜根治膀胱全切(robotic-assisted radical cystectomy,RRC)已成为许多世界知名腹腔镜中心的治疗膀胱肿瘤的标准术式之一。检索MEDLINE?/PubMed?数据库,总结1992年以来发表的有关LRC或RRC术后完全体内尿流改道的文献,结果发现LRC或RRC术后越来越多的尿流改道倾向于腹腔镜下完全体内尿流改道。目前全世界已经积累病例数量超过173例,逐步成为LRC或RRC术后尿流改道重建技术的常规选择。LRC或RRC术后完全体内尿流改道是可行的,具有可重复性、为患者提供创伤小和术后恢复快等方面益处,但需要长期的肿瘤学及功能性证据,以确定其在膀胱癌治疗中的作用。
Laparoscopic radical cystectomy (LRC) or robotic-assisted radical cystectomy (RRC) has become one of the standard surgical procedures for bladder cancer in many world-renowned laparoscopic centers. The MEDLINE ™ / PubMed ™ database was searched to summarize the literature published since 1992 on complete urinary diversion in vivo after LRC or RRC and found that more and more urinary diversions following LRC or RRC tended to be completely laparoscopic Urinary diversion. At present, more than 173 cases have been accumulated in the world and gradually become the routine choice of urinary diversion reconstruction techniques after LRC or RRC. Complete in-vivo urinary diversion in LRC or RRC is feasible and reproducible, providing patients with less trauma and faster postoperative recovery benefits, but long-term oncologic and functional evidence is needed to determine whether bladder cancer The role of treatment.